Proprietary Drug Delivery Assets (Santa Barbara) is Buildings and Property in United States that focus on drug delivery assets business. They cover business area such as proprietary drug delivery asset, Khalay HATM, hyaluronic acid, wrinkle reduction, CyclopsorbTM, to moderate psoriasis.
-
Drug Delivery Assets
-
Department of Chemical Engineering
Engineering II, University of California
Santa Barbara, CA 93106
United States
Private
proprietary drug delivery assetKhalay HATMhyaluronic acidwrinkle reductionCyclopsorbTMto moderate psoriasis
* We use standard office opening hours in near Proprietary Drug Delivery Assets (Santa Barbara)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Proprietary Drug Delivery Assets (Santa Barbara) is Buildings and Property business from United States that founded in - ( years old in ), Proprietary Drug Delivery Assets (Santa Barbara) business is focusing on Drug Delivery Assets.
Proprietary Drug Delivery Assets (Santa Barbara) headquarter office and corporate office address is located in Department of Chemical Engineering Engineering II, University of California Santa Barbara, CA 93106 United States.
Proprietary Drug Delivery Assets (Santa Barbara) was founded in United States.
In , Proprietary Drug Delivery Assets (Santa Barbara) is currently focus on drug delivery assets sector.
Above is snippet of Google Trends for "drug delivery assets" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Proprietary Drug Delivery Assets (Santa Barbara), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
